Specify a stock or a cryptocurrency in the search bar to get a summary
M1 Kliniken AG
M12M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for plastic and aesthetic surgery; and medical specialist centers for aesthetic and plastic medicine under the Schlossklinik and M1 Med Beauty names. The Trade segment sells pharmaceuticals and medical products for various therapeutic areas comprising oncology, HIV/AIDS, neurology, rheumatology, other chronic diseases, and aesthetic medicine. The company was incorporated in 2007 and is based in Berlin, Germany. M1 Kliniken AG is a subsidiary of MPH Health Care AG. Address: GrUenauer Strasse 5, Berlin, Germany, 12557
Analytics
WallStreet Target Price
24.69 EURP/E ratio
19.4444Dividend Yield
2.83 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures M12
Dividend Analytics M12
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
54 %Dividend History M12
Stock Valuation M12
Financials M12
Results | 2019 | Dynamics |